All In MedTech

Device Trial Radar · NCT07335861

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers

Evaluation of the Efficacy of Hyalomatrix® in the Healing of Chronic Venous Leg Ulcers: A Randomized Controlled Multicenter Crossover Trial

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

122

Planned (sponsor's estimate)

Start

May 14, 2026

Primary completion

Dec 31, 2026

Study completion Jan 31, 2027

Sponsor

Lead sponsor
NuScience Medical Biologics, LLCNot on our public-company list
Sponsor type
Industry
First posted
Jan 13, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.

Conditions

  • Venous Leg Ulcer
  • Chronic Wounds

Interventions

  • HyalomatrixDevice

    Hyalomatrix is a hyaluronic acid-based wound dressing designed for advanced wound therapy.

  • Standard of CareOther

    Wound cleansing, Sharps debridement, Dressing for moisture balance, Compression therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Wound ClosureTime frame: 1-12 weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • MedCentris of Alexandria

    Alexandria, Louisiana · Recruiting

  • MedCentris of Hammond

    Hammond, Louisiana · Recruiting

  • MedCentris of Lafayette

    Lafayette, Louisiana · Not yet recruiting

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.